| Product Code: ETC13261549 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Infectious Disease Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Infectious Disease Drug Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Infectious Disease Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Infectious Disease Drug Market - Industry Life Cycle |
3.4 Middle East Infectious Disease Drug Market - Porter's Five Forces |
3.5 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Source Type, 2021 & 2031F |
3.7 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Mode of Action Type, 2021 & 2031F |
3.10 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.11 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 Middle East Infectious Disease Drug Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Middle East Infectious Disease Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Infectious Disease Drug Market Trends |
6 Middle East Infectious Disease Drug Market, 2021 - 2031 |
6.1 Middle East Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Bacterial Diseases, 2021 - 2031 |
6.1.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Virusal Diseases, 2021 - 2031 |
6.1.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Fungal Disease, 2021 - 2031 |
6.1.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Parasitic Disease, 2021 - 2031 |
6.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Jaundice, 2021 - 2031 |
6.2.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Leprosy, 2021 - 2031 |
6.2.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Listeria, 2021 - 2031 |
6.2.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Lyme Disease, 2021 - 2031 |
6.2.6 Middle East Infectious Disease Drug Market, Revenues & Volume, By Malaria, 2021 - 2031 |
6.2.7 Middle East Infectious Disease Drug Market, Revenues & Volume, By Measles, 2021 - 2031 |
6.2.8 Middle East Infectious Disease Drug Market, Revenues & Volume, By Molluscum Contagiosum, 2021 - 2031 |
6.2.9 Middle East Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.3.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Dietary Supplements, 2021 - 2031 |
6.3.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Antibacterial Drugs, 2021 - 2031 |
6.4.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Antiviral Drugs, 2021 - 2031 |
6.4.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Antifungal Drugs, 2021 - 2031 |
6.4.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Antiparasitic Drugs, 2021 - 2031 |
6.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Tafenoquine, 2021 - 2031 |
6.5.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Omadacycline, 2021 - 2031 |
6.5.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Tecovirimat, 2021 - 2031 |
6.5.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Eravacycline, 2021 - 2031 |
6.5.6 Middle East Infectious Disease Drug Market, Revenues & Volume, By Delafloxacin, 2021 - 2031 |
6.5.7 Middle East Infectious Disease Drug Market, Revenues & Volume, By Plazomicin, 2021 - 2031 |
6.5.8 Middle East Infectious Disease Drug Market, Revenues & Volume, By Benznidazole, 2021 - 2031 |
6.5.9 Middle East Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Middle East Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.6.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Topical, 2021 - 2031 |
6.6.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.7 Middle East Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.7.3 Middle East Infectious Disease Drug Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.7.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.7.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Middle East Infectious Disease Drug Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.2.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Source Type, 2021 - 2031 |
7.3 Middle East Infectious Disease Drug Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 Middle East Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 Middle East Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.5.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Mode of Action Type, 2021 - 2031 |
7.6 Middle East Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.6.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.7 Middle East Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.2 UAE Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.6 Oman Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8 Middle East Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.1 Saudi Arabia Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.2 UAE Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.3 Kuwait Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.4 Qatar Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.5 Bahrain Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.6 Oman Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.7 Turkey Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8.8 Rest of Middle East Infectious Disease Drug Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Middle East Infectious Disease Drug Market Key Performance Indicators |
9 Middle East Infectious Disease Drug Market - Export/Import By Countries Assessment |
10 Middle East Infectious Disease Drug Market - Opportunity Assessment |
10.1 Middle East Infectious Disease Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Infectious Disease Drug Market Opportunity Assessment, By Source Type, 2021 & 2031F |
10.3 Middle East Infectious Disease Drug Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 Middle East Infectious Disease Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.5 Middle East Infectious Disease Drug Market Opportunity Assessment, By Mode of Action Type, 2021 & 2031F |
10.6 Middle East Infectious Disease Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.7 Middle East Infectious Disease Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.8 Middle East Infectious Disease Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 Middle East Infectious Disease Drug Market - Competitive Landscape |
11.1 Middle East Infectious Disease Drug Market Revenue Share, By Companies, 2022 |
11.2 Middle East Infectious Disease Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here